Thomas Loh, MD
Vascular Surgery · Shenandoah, TXNPI 1376803106
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (37.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Inari Medical, Inc. accounts for 74.2% of it on its own, with 59 other manufacturers making up the rest. Reporting peaked in 2022 at $71,376 and has fallen 71.5% since, to $20,330 in 2025. Among vascular surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 688 payments — averaging $291.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$149K
- Biom'up France SAS$11K
- Stryker$10K
- Medtronic$9K
- Boston Scientific$7K
- W. L. Gore & Associates, Inc.$2K
- plus $13K from 54 others
Across 1 payment — averaging $10,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Penumbra, Inc.$10K
What the payments were for
- Consulting fees$76,09038%
- Speaking & faculty fees$64,65032%
- Travel & lodging$31,17616%
- Food & beverage$28,64614%
- Education$880%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$157,635
- FLOWTRIEVER CATHETER, S$154,604
- HemoBlast Bellows$10,758
- IN.PACT Admiral$5,266
- GENERAL - THERAPIES$3,750
- Indigo System$1,734
- ENROUTE Transcarotid Neuroprotection System$1,657
- ENROUTE Transcarotid Stent$1,033
- JETSTREAM$833
- Abre$661
- FlowTriever$534
- ClotTriever$534
- PREVELEAK$508
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$473
- Admiral Xtreme$419
- VIABAHN VBX Balloon Expandable Endoprosthesis$405
- VenaSeal$353
- GORE VIABAHN Endoprosthesis with Heparin$350
- HeRO Graft$340
- EKOSONIC$317
How this compares
$200,650 in reported general payments places this provider in the 95th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 114 | $74,216 |
| XareltoRivaroxaban | 30 | $23,129 |
| ClopidogrelClopidogrel Bisulfate | 98 | $1,316 |
| Cilostazol | 19 | $271 |
| Atorvastatin Calcium | 19 | $228 |
| Gabapentin | 15 | $176 |
| Methylprednisolone | 12 | $67 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $37 | $74,216114 claims |
| Johnson & JohnsonXarelto | $257 | $23,12930 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in Shenandoah
- Gregory PearlDallas$2.3M
- Mazin FotehAustin$1.6M
- Alan LumsdenHouston$742K
- Stephen HohmannDallas$499K
- Michael SiahDallas$392K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Carlos TimaranDallas$231K
- Dennis GableDallas$211K
- Eric TrestmanHumble$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.